LIBMELDY OPTIONS

The tablet formulation of zanubrutinib (Brukinsa; BeOne) is now authorized for all five indications throughout many hematological cancers.Nala's MLD was identified as well late for her being dealt with. She is currently unable to stroll or discuss, and should be tube-fed.The approval helps make atidarsagene autotemcel (arsa-cel [Lenmeldy]; Orchard